# Anti-EGFR Immunoliposomes in Solid Tumors

> **NCT01702129** · PHASE1 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 26 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** anti-EGFR immunoliposomes loaded with doxorubicin

## Key facts

- **NCT ID:** NCT01702129
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01702129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01702129, "Anti-EGFR Immunoliposomes in Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01702129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*